Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Twist Bioscience

Biotech & Life Sciences · South San Francisco, United States · Founded 2013 · IPO 2018 Unicorn

Develops a proprietary semiconductor-based synthetic DNA manufacturing process

Valuation
$3.48B
Market cap · May/2026
Revenue
$377M
Latest reported FY

Investors

19 investors on Twist Bioscience's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Paladin Capital Group
ARCH Venture Partners
Asset Management Ventures
Series B+ 16 investors entered at this stage
Joby Pritzker
3W Partners
Cormorant Asset Management
Reinet Investments S.C.A.
Biomatics Capital Partners
Illumina
Boris Nikolic
+ND Capital
WuXi Healthcare Ventures
Yuri Milner
Illumina Ventures
ARCH Overage Fund
FIS
Tao Venture Partners
Dentsu Ventures
Foresite Capital

Global footprint

Where Twist Bioscience has talent and traffic

AI talent share
0.6% of workforce is AI talent
(7 of 1,270 staff)
Core AI10.08%
Other AI60.47%
Non-AI workforce1,26399.45%
Workforce by country
25 countries with
team presence
🇺🇸 United States84.6%
🇬🇧 United Kingdom2.7%
🇩🇪 Germany1.9%
🇸🇬 Singapore1.5%
🇮🇱 Israel1.3%
Top 5 of 25 shown
Web traffic by country
190K monthly visits
across markets
🇺🇸 United States33.2%
🏳️ Korea6.1%
🏳️ Republic of6.1%
🇬🇧 United Kingdom5.3%
🇵🇪 Peru5.2%
Top 5 markets shown

Patent intelligence

$84M patent portfolio · 108 active families

Estimated portfolio value
$84M
2.4% of market cap · 2.8× the top peer Krystal Biotech ($30M)
108 active patent families
Where Twist Bioscience innovates PolynucleotideNucleic acid sequencingNucleic acid sequenceBiological organismMolecular biology

Where Twist Bioscience concentrates vs peers

Each axis is a top-10 topic across Twist Bioscience and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Twist Bioscience's 5 investments and acquisitions.

Every disclosed deal where Twist Bioscience appeared as a backer or acquirer, 2016–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Twist Bioscience's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Twist Bioscience deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Twist Bioscience's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        What the market is saying about Twist Bioscience

        An AI-synthesized read of the highest-engagement posts about Twist Bioscience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Twist Bioscience on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.